Related Experiment Video
Updated: May 7, 2026
Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
Published on: August 29, 2012
De novo and quiescent cGVHD are distinguishable in a prognostic biomarker panel
Lara Vollmer1,2, Katharina M Habenicht1,2, Andrea Schneider2
1Department of Internal Medicine 5 - Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany.
Insights
Identifying biomarkers for chronic graft-versus-host disease (cGVHD) after stem cell transplant is crucial. This study found specific protein profiles that predict cGVHD development and progression, aiding early intervention strategies.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Chronic graft-versus-host disease (cGVHD) is a major complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT).
- Current treatment for cGVHD begins after clinical onset, often when irreversible damage has occurred.
- Reliable prognostic biomarkers are needed for early detection and pre-emptive intervention in high-risk patients.
Purpose of the Study:
- To identify potential prognostic biomarkers for predicting the development and course of cGVHD post-allo-HSCT.
- To explore the utility of serum cytokine and chemokine profiles in distinguishing cGVHD patient subgroups.
- To understand the biological heterogeneity of cGVHD for improved predictive modeling.
Main Methods:
- Serum samples from 60 adult allo-HSCT recipients were analyzed at 90 and 180 days post-transplant.
- Bead-based multiplex analysis was employed to quantify protein levels.
- Patients were categorized based on the development of de novo cGVHD, quiescent cGVHD, or resolved acute GVHD.
Main Results:
- Specific serum protein levels (BAFF, CCL4, CXCL9, sRAGE) differentiated patients with de novo cGVHD from those without GVHD.
- Elevated levels of IL-6, IL-17A, PAI-1, IL-10, CX3CL1, CXCL1, and CCL4 were prognostic for quiescent cGVHD compared to resolved acute GVHD.
- These findings suggest distinct biological profiles associated with different cGVHD clinical courses.
Conclusions:
- The study identified ten cytokines and chemokines with potential prognostic value for cGVHD.
- Serum protein profiles can distinguish between different cGVHD phenotypes.
- Future predictive models for cGVHD should consider clinical subgroups and prior disease history, moving beyond single-biomarker approaches.
Abstract:
Chronic graft-versus-host disease (cGVHD) remains the most significant long-term complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT), despite increasing insights into its pathogenesis. The development of reliable prognostic biomarkers is essential for identifying patients at high risk of developing cGVHD which may benefit from pre-emptive intervention. However, valid biomarkers remain elusive, and cGVHD is typically treated after clinical onset only, when irreversible manifestations such as ocular involvement may already be present. In this exploratory study, we identified ten cytokines and chemokines with potential prognostic value for predicting subsequent cGVHD. Using bead-based multiplex analysis, we assessed serum samples from 60 adult allo-HSCT recipients at day +90 and day +180 post-transplant to identify proteins distinguishing patients who later developed cGVHD from those who remained tolerant. Significant differences were found in the serum levels of BAFF, CCL4, CXCL9, and sRAGE between patients with de novo cGVHD and those without GVHD. In contrast, elevated IL-6, IL-17A, PAI-1, IL-10, CX3CL1, CXCL1, and CCL4 levels were prognostic for quiescent cGVHD compared with patients with resolved acute GVHD only. These findings underscore the biological heterogeneity of cGVHD and the limited value of single-biomarker approaches, emphasizing the need to consider distinct clinical subgroups and prior disease courses in future predictive models.
More Related Videos
09:00High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
Related Concept Videos
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:27Cytomegalovirus Disease